Previous close | 0.1500 |
Open | 0.1600 |
Bid | 0.0100 |
Ask | 0.0300 |
Strike | 107.00 |
Expiry date | 2024-05-24 |
Day's range | 0.1500 - 0.1600 |
Contract range | N/A |
Volume | |
Open interest | 30 |
Sanofi (SNY) inks collaboration deal with Formation Bio and OpenAI to build AI-powered software to advance drug development and create new medicines.
Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi said the partnership with OpenAI will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources. The three teams will combine data, software, and tuned models t
Moderna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year...